Novo Nordisk Aktie

74,50EUR -0,93EUR -1,23%
Novo Nordisk für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN DE: A3EU6F / ISIN: DK0062498333
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Personal

2020 2021 2022 2023 2024
Personal am Ende des Jahres 45 323 47 792 54 393 63 370 76 302
Umsatz pro Mitarbeiter in Mio. EUR 2,80 2,95 3,25 3,67 3,81

Bilanz (in Mio. DKK) - Aktiva

2020 2021 2022 2023 2024
Summe Umlaufvermögen 65 809 85 595 108 194 139 646 160 897
Summe Anlagevermögen 79 113 108 913 133 063 174 840 304 898
Summe Aktiva 144 922 194 508 241 257 314 486 465 795

Bilanz (in Mio. DKK) - Passiva

2020 2021 2022 2023 2024
Summe Fremdkapital 81 597 123 762 157 771 207 925 322 309
Summe Eigenkapital 63 325 70 746 83 486 106 561 143 486
Summe Passiva 144 922 194 508 241 257 314 486 465 795

Adresse

Novo Allé 1, 2880 Bagsværd
Internet http://www.novonordisk.com

Management

Andreas Fibig
Independent Director
Camilla Sylvest
EVP-Commercial Strategy & Corporate Affairs
Christina Law
Independent Director
Douglas Langa
EVP & Head-North America Operations
Elisabeth Dahl Christensen
Non-Independent Director
Helge Lund
Chairman
Henrik Ehlers Wulff
Executive VP-Product Supply, Quality & IT
Henrik Poulsen
Vice Chairman
Irina Ivanischeva
Vice President & General Manager
Jacob Martin Wiborg Rode
Head-Investor Relations
Jane Buus Laursen
Corporate Vice President
Karsten Munk Knudsen
Chief Financial Officer & Executive Vice President
Kasim Kutay
Non-Independent Director
Kristine Færch
Project Director-Data Science
Lars Fruergaard Jørgensen
President & Chief Executive Officer
Laurence Debroux
Independent Director
Liselotte Hyveled
Chief Patient Officer & Non-Independent Director
Ludovic Helfgott
Executive Vice President & Head-Rare Disease
Marcus Schindler
Chief Scientific Officer & Executive VP-Research
Martin Holst Lange
Executive Vice President-Development
Martin W. MacKay
Independent Director
Maziar Mike Doustdar
Executive Vice President-International Operations
Mette Bøjer Jensen
Non-Independent Director
Mette Zacho
Vice President
Robin Evers
Senior VP & Head-Global Regulatory Affairs
Stephen Gough
Global Chief Medical Officer
Sylvie Louise Grégoire
Independent Director
Tania Sabroe
Executive VP-Global People & Organisation
Thomas Rantzau
Non-Independent Director
Tina Abild Olesen
Senior Vice President-Global Diabetes Franchise